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Summary 
Experimental allergic encephalomyelitis (EAE) is a demyelinating autoimmune disorder that can 
be induced in susceptible mice by T  lymphocytes sensitized to central nervous system (CNS) 
myelin components and is a prime animal model for the human CNS demyelinating disorder, 
multiple sclerosis  (MS). Although CNS inflammation in which T  lymphocytes and activated 
macrophages are the predominant cell types is observed in mice with EAE and in humans with 
MS, the exact mechanisms underlying the CNS damage and demyelination are not understood. 
Nitric oxide (NO),  a gaseous free radical, has recently been shown to be a cytolytic product 
of activated macrophages. Using electron paramagnetic resonance spectroscopy, the nitric oxide 
free radical complexed with iron-sulfur proteins has been identified in affected spinal cords of 
mice with EAE, concurrent with the diminution of iron-sulfur proteins. These results indicate 
NO may play a role in the disease process of EAE,  and perhaps MS. 
E 
AE is a cell-mediated autoimmune demyelinating disorder 
that can be induced in several species. The murine form 
of EAE induced by adoptive transfer of CD4 + myelin basic 
protein-specific T lymphocytes is especially useful as a model 
due to its clinical and histologic similarities to the human 
central nervous system (CNS) 1 inflammatory demyelinating 
disease multiple sclerosis  (MS)  (1-3).  Macrophages form a 
significant component of the inflammatory cells in lesions 
of acute and chronic EAE and MS, and are the effector cells 
of demyelination (4, 5). However, the pathogenetic mecha- 
nisms underlying myelin damage and the production of neu- 
rologic signs for both disorders are not known. 
Nitric oxide (NO), a free radical generated from guanidino 
nitrogens of r-arginine (6) in a reaction catalyzed by nitric 
oxide synthase (NOS),  is now considered to be a biologic 
mediator (7-9).  Recently, it has been shown that activated 
macrophages (as well as other cell types) synthesize large 
amounts of NO via a distinct,  inducible isoform of NOS 
(iNOS) (10).  NO thus generated appears  to be under im- 
munologic control (11, 12) and to be cytotoxic (13). Further- 
more, NO may be a mediator of immune function (14) and 
1 Abbreviations used in this paper: CNS,  central  nervous  system; EPR, 
electron paramagnetic resonance; MBP, myelin basic protein; MS, multiple 
sclerosis; NO, nitric oxide; NOS, nitric oxide synthase. 
play a role in some autoimmune disorders (15), including EAE 
(16).  Since electron paramagnetic  resonance (EPR)  spec- 
troscopy is the definitive method by which free radicals can 
be identified and quantified (17), the present study investigated 
the presence of NO or its paramagnetic products in CNS, 
blood,  and organs of mice with EAE using EPR. 
Materials  and Methods 
Induction of EAE.  Female  SJL/J mice (The Jackson Laboratory, 
Bar Harbor, ME), 6-8 wk of age, were maintained in accordance 
with National Institutes of Health guidelines  in microisolators.  EAE 
was induced by a method that is routine in our laboratory (18). 
Briefly, myelin basic protein (MBP) was prepared from guinea pig 
spinal cords (Rockland Inc., GilbertsviUe,  PA) as described (19) and 
donor mice were immunized over the flanks with 0.4 mg MBP 
in CFA containing Myrobacterium tuberculosis H37Ra (Difco Labora- 
tories, Detroit, MI). f0 d later the draining lymph nodes were re- 
moved, made into a single-ceU  suspension, and cultured 3 d with 
50/~g MBP/ml. After washing, 0.5-1  x  10  s cells were injected 
intravenously into syngeneic recipients, which developed clinical 
relapsing and remitting EAE. Mice were scored from 0 to 5 (0, 
normal; 1, limp tail; 2, difficulty righting; 3, one limb plegic; 4, 
two limbs plegic; 5, three limbs plegic, moribund) every 1-2 d using 
a published scale (20). 
Preparation of Tissue Samples for EPR.  At the time of death, 
anesthetized mice were bled from the heart, then perfused through 
the left cardiac ventricle with cold, sterile PBS to remove blood 
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cords were removed intact and immediately frozen on dry ice in 
<10 min after death. Spinal  cord weights ranged from 0.11 to 0.15 g. 
Blood was introduced into a quartz tube and frozen on dry ice 
within 2-5 min. In some cases, spleens and livers were removed 
and frozen on dry ice within 5 min of death. 
Treatment of Spinal Cord Tissue with NO.  To characterize the 
EPR spectra of the nitrosyl iron-sulfur protein complexes, '~0.05 
ml of deoxygenated  acetonitrile (CH3CN) saturated with NO gas 
was mixed with spinal cords from naive SJL mice as a positive con- 
trol. To do this, acetonitrile in a vial capped with a rubber septum 
was first bubbled with nitrogen gas for 5 min to remove any dis- 
solved gases, especially 05.  NO  gas (Matheson Gas Products, 
Secaucus, NJ) was then bubbled through the liquid acetonitrile for 
1-2 min, after which the saturated solution was applied to the spinal 
cords in the EPR sample tube. The sample was immediately frozen 
on dry ice after the mixing. 
Electron Pan,  magnetic Resonance.  EPR spectra were measured  on 
spinal cords, the main area of pathology in our model (4), and blood 
from EAE-affected  and healthy control SJL mice soon after death. 
Spleens and livers from two affected mice and two controls were 
also analyzed. An X-band spectrometer (ER200; Bruker, Billerica, 
MA) equipped with an EPR cryostat (4.2-300 K; Oxford Scientific, 
Concord, MA) was used. Signal  averaging  and data processing  were 
implemented by an additional 12-bit analog/digital converter and 
a Scientific  EPtL software package. For each spectral analysis, two 
spinal cords were introduced into a 3--4-ram quartz tube (Wilmad 
Glass, Buena, NJ) and were stored at  -70~  when not in use. 
To improve signal-to-noise, most of the present studies were per- 
formed within 3 h of  death at cryogenic  helium temperatures (10-20 
K), with tissues  being kept at -70~  during the intervening time. 
To compare the intensity of the peaks at g  =  2.04 from experi- 
ment to experiment, an "intensity  index" defined as: 10x  (height 
of the peak at g  =  2.04/the  sum of the heights of the peaks at 
g  -~ 2.04 and 1.93) was determined for each pair of spinal cords. 
The peaks at g  =  2.04 and 1.93 represented nitrosyl iron-sulfur 
complexes and iron-sulfur protein, respectively (see below). 
Statistical Evaluation.  The Student's t test was used to compare 
theg = 2.04 intensity indices of the EAE-affected  and control spinal 
cord pairs. 
Results 
EPR Spectra of Normal Mouse Spinal Cords Exposed to NO 
Gas.  By EPR, NO has been shown to bind to iron-sulfur 
proteins resulting in an iron-nitrosyl complex with a charac- 
teristic g value of 2.04 (21-23).  To confirm this with mouse 
spinal cords,  EPR experiments were performed before and 
after a portion of deoxygenated acetonitrile saturated with 
NO was introduced to spinal  cords taken from two naive 
mice.  The results showed that NO induced a peak at g  = 
2.04 that was not seen in the spectra of the untreated spinal 
cords (Fig.  1). Signal intensity at g  =  2.02 and 1.93 (iron- 
sulfur proteins; see below) noted in the untreated spinal cords 
were markedly reduced in the spectra of spinal cords exposed 
to NO (Fig.  1). The g  =  2.04 intensity index was 7.1 for 
the cord pair treated with NO gas.  Residual blood in the 
spinal cords bound to excess NO to give a distinct NO-Fe 
heme protein signal at g  =  2.01  with a set  of three 14N 
hyperfme splittings (amplitude  --  17 Gauss). 
Iron-Sulfur Proteins in Mouse Spinal Cords.  Oxidized iron- 
g = 2.02  g: I, 93 
g =  2.04 
I 
Figure  1.  EPIL  spectra of spinal cords from naive mice at 20 K: (A) 
before exposure to NO, (B) after  exposure to NO dissolved  in acetonitrile 
(positive  control). Experimental  settings:  microwave  frequency,  9.4437 GHz; 
modulation frequency,  100 KHz; modulation  amplitude, 6.3 G; micro- 
wave power, 0.64 mW. 
sulfur centers exhibit a fast-relaxing axial signal at g  =  2.02 
at liquid helium temperatures that disappears when the tem- 
perature increases to 30 K  (21). Another iron-sulfur signal 
occurs at g  =  1.93 (24).  EPtL spectra from 16 of 20 spinal 
cord pairs  studied (32 of 40 EAE-affected and positive and 
negative control mice) were obtained at cryogenic helium tem- 
peratures (10-20  K). All 16 pairs exhibited signals  at g  = 
2.02 and 1.93, with the identical temperature dependence of 
iron-sulfur proteins (Fig.  2).  The relative intensities of the 
iron-sulfur peaks  (g  =  1.93) were more prominent in the 
spinal cord pairs from naive mice when compared with those 
of affected mice (Table 1). 
Iron-Nitrosyl Complexes in Spinal Cords of Mice with EAE. 
All 10 spinal cord pairs from SJL mice with EAE (clinical 
grades  1-4.5) exhibited EPR signals  at g  =  2.04  (Table 1 
and Fig. 3). In the initial EPR experiments, we analyzed three 
pairs of EAE-affected spinal cords at cryogenic nitrogen tem- 
peratures (-100~  and all three showed a small peak at 
g  =  2.04  with signal-to-noise ratio •2.  Two pairs of the 
three were from acutely ill mice with scores of 2.5 and 4.0 
in the first pair and both 4.0 in the second pair. The third 
pair derived from chronically ill mice with scores of 1.0 and 
4.0. One pair of control unaffected  cords analyzed at -100~ 
showed zero intensity at g  =  2.04.  To improve signal-to- 
noise, all subsequent spinal cord pairs were examined by EPR 
at cryogenic hdium temperatures (10-20 K). The g  =  2.04 
signal was further characteristic of iron-nitrosyl complexes 
(8, 24) in that it did not consist of a fast-relaxing component 
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Figure 2.  EPR spectra of spinal cord of an EAE-affected  SJL mouse 
at various temperatures: (A) 10, (B) 70, and (C) 100 K. Experimental 
settings: microwave  frequency,  9.45 GHz; modulation  frequency,  100 KHz; 
modulation amplitude, 5 G; microwave  power, I mW. The stable radical 
1,1-diphenyl-2-picrylhydrazyl  (DPPH) was used as a g value  marker (g = 
2.0037). Note that the signal-to-noise  ratio for the peak at g = 2.04 in 
A is higher than that in B or C. 
(it could still be observed at 70 K in contrast to the signals 
at g  =  2.02 and 1.93 that disappear at temperatures ;>30 K; 
see Fig.  2). The g  ==  2.04 intensity index was significantly 
greater (p  =  0.002)  for the spinal cord pairs  from affected 
mice with EAE than for spinal cord pairs of naive mice (Table 
1 and Fig. 3). 
EPR Measurements of Blood and Other Tissues.  To inves- 
tigate whether NO production was increased systemically  in 
mice with EAE, EPR measurements on individual samples 
of spleen and liver from two mice with EAE and two con- 
trols were performed. No EPR signals corresponding to iron- 
nitrosyl complexes were observed.  Within blood samples, 
nitrosyl-heme proteins would be expected if NO were present 
(8). We did not observe  nitrosyl-heme proteins (g  =  2.012 
and 2.069) in 10 samples of  blood from naive and EAE-affected 
mice that were frozen immediately after removal and ana- 
lyzed by EPR within 4 h of death (data not shown). The 
absence of observable  NO bound to Fe in heme proteins in 
blood or other organs may be attributable to the rapid reac- 
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Figure  3.  EPR spectra of spinal  cords of SJL/J mice  at 10 K. (A) Two 
EAE-affected  cords (clinical  grades 1.5 and 3); (B) two naive  mouse  cords. 
Note the presence of a peak at g ~ 2.04 in A and the t~luction in the 
iron-sulfur  protein peaks atg = 2.02 and 1.93 in the affected  (A) as com- 
pared with control (B) spinal cord. The broad background in A is due 
to residual heme. Experimental settings same as those of Fig. 2. 
tion of NO with 02, O2-, and oxyhemoglobin to produce 
nitrate and methemoglobin (25).  However, the g  =  2.01 
NO-Fe heme protein signal with three 14N hyperfine split- 
tings due to residual blood could be detected in some spinal 
cords pairs  from mice with EAE. 
Discussion 
In the present study, iron-nitrosyl complexes were identified 
by EPR spectroscopy in the target organ (spinal cord) of mice 
with the CNS autoimmune demyelinating  disorder EAE. The 
complexes were significantly smaller in spinal cords of healthy 
control mice, indicating that the g  =  2.04 signal was not 
due to the small amount of NO known to be formed by en- 
dothelial cells and neurons (26) via the constitutive isoform 
of NOS (27). Iron-nitrosyl complexes were not observed in 
other organs of mice with EAE or control mice. The levels 
of iron-nitrosyl complexes observed  in EAE-affected spinal 
cords were comparable to the high levels obtained when NO 
is synthesized via iNOS. 
The reactivity of NO with other paramagnetic species such 
as iron (Fe  2+) and oxygen is often deleterious to living cells 
(8).  Much of the toxicity of NO is due to its high affinity 
for metalloproteins; release of NO with subsequent binding 
to and destruction of iron-sulfur centers (at near physiologic 
temperatures) causes tissue dysfunction via inhibition of the 
Krebs cycle, the electron transport chain, and DNA synthesis 
(28). Iron-sulfur centers, important to the function of  a number 
of enzymes, can be identified by EPR (24).  In cells treated Table  1.  Summary of EPR Findings on Spinal Cords at Cryogenic Helium Temperatures 
Intensity 
Exp.  Clinical  index  at 
Mice  and Run*  Mouse  grade*  DPTS  g  =  2.04" 
EAE 
Control 
1  69/72  1/4  46/46  5.0 
2A  65/74  1.5/3  59/59  3.8 
3A  109/112  1/1.5  15/15  1.8 
4  110/113  4/4  15/15  2.6 
5A  76/97  1.5/3  75/48  2.2 
6A  139/140  4.5/4  28/28  2.5 
7A  260/262  1/4  14/14  4.4 
2B  114/115  Naive/naive  -/-  1.2 
3B  116/117  Naive/naive  -/-  1.4 
5B  591/621  0/0  94/94  1.2 
6B  155/156  Naive/naive  -/-  0.0 
7B  275/276  Naive/naive  -/-  1.4 
8  170/171  Naive/naive  -/-  0.5 
9  216/217  Naive/naive  -/-  0.6 
10  218/219  Naive/naive  -/-  0.4 
Spinal cords were analyzed in groups of two for EPR measurement. 
" Subsets A and B of the same numeral refer to EAE-affected and control mice, respectively, killed and analyzed by EPR on the same day under 
identical EPR settings. 
* Clinical grade 0-5 (see Materials and Methods). 
S DPT, days post-cell transfer. 
II Intensity Index as described in Materials and Methods. 
1 Never clinically ill. 
with NO, the iron-sulfur signal is known to decrease,  with 
concurrent appearance of iron-nitrosyl signal (21), and in the 
present  study when normal  spinal cords were treated with 
NO, iron-sulfur  signals became greatly diminished.  In the 
affected spinal cords of mice with EAE,  the ratio of iron- 
sulfur to iron-nitrosyl peaks was decreased in comparison with 
that  in naive controls.  This indicated that  iron-sulfur  pro- 
teins had converted to iron-nitrosyl  complexes by reacting 
with  NO. 
The present  study demonstrated NO production largely 
confined to the target organ in EAE, the CNS. The lack of 
strict correlation of the magnitude of the iron-nitrosyl com- 
plex with clinical scores remains unexplained, but may reflect 
sampling errors (e.g., involvement of the brainstem or cere- 
bellum, which were not studied), the imprecise nature of the 
clinical scoring system, or the involvement of multiple factors 
in addition to NO in determining disease manifestations. No 
EPR signals corresponding to nitrosyl-heme proteins within 
the peripheral blood could be identified.  Although hepato- 
cytes are known to be induced by cytokines (IFN-% TNF) 
to produce NO (29), an iron-nitrosyl signal was not observed 
in the liver,  an organ unaffected by EAE. Perhaps any NO 
released from the CNS reacted locally with oxygen or su- 
peroxides before binding  to heme proteins in the blood or 
distal organs. 
The mechanisms leading to tissue damage in EAE and MS 
remain  enigmatic.  Though  CD4 + myelin-specific T  lym- 
phocytes are known to be the cells inducing EAE, most of 
the inflammatory cells within acute EAE lesions are nonspecific 
(30,  31),  and  include  CD4 +  and  CD8 §  T  cells,  macro- 
phages, B lymphocytes, and neutrophils (4). In addition, other 
cells might  be the source of increased NO production.  In 
the rat model of EAE, NADPH diaphorase staining (known 
to recognize NOS) localized to the vasculature, suggesting 
upregulation of NOS in vascular or perivascular cells (K. G. 
Tilton, unpublished observations).  Activated macrophages play 
a crucial role in EAE (32) and are particularly numerous in 
chronic,  active lesions (33). Furthermore, two cytokines, IFN- 
"y and TNF, known to be important  to the development of 
EAE (34, 35) and present in MS lesions (36, 37), upregulates 
iNOS  (38). 
The observation of NO products within spinal cords affected 
by EAE raises the possibility that some of the tissue dysfunc- 
tion and destruction in the EAE model may be secondary 
to local NO production.  Furthermore,  the NO free radical 
in target tissues of EAE in association with a relative decrease 
in iron-sulfur proteins suggests a potential pathogenetic mech- 
anism. Additional support for a pathogenic role for NO in 
EAE was obtained when mice induced to develop EAE and 
treated with the iNOS-inhibitor aminoguanidine (39, 40) dis- 
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mice (Cross, A. H., R. F. Lin, T. P. Misko, W. F. FIickey, 
J. L. Trotter, and R. G. Tilton, manuscript in preparation). 
Cytotoxic effects of NO might impair the ability of oligo- 
dendroglia to remyelinate axons and might be involved in 
oligodendroglial cell loss from affected tissues (41). Similarly, 
the axonal destruction that occurs in EAE (42)  might in- 
volve NO toxicity. The present findings extend understanding 
of the pathogenic processes in the EAE model and may pro- 
vide insight for its human counterpart, MS. 
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